Uterine fibroids are noncancerous growths of the uterus, or womb, that often appear during a woman's childbearing years. They develop from the smooth muscular tissue of the uterus. A single cell divides over and over, eventually creating a firm, rubbery mass. They may grow slowly or rapidly, or remain the same size. They often shrink or disappear after pregnancy, when the uterus goes back to a normal size, and they often go away after menopause. Uterine fibroids range in size from tiny to bulky masses that can enlarge the uterus. Rarely, a fibroid can cause pain and abnormal bleeding. There are three different types of fibroids, defined by where they grow in the uterus.
UAB Obstetrics and Gynecology offers comprehensive women's health care in a private, personal environment, with physicians and nurses who are dedicated to delivering excellent care. Because our physicians are nationally recognized specialists in their fields, you can rest assured that you are receiving the most advanced care available. UAB Obstetrics and Gynecology is consistently ranked among the best programs of its kind in the country by U.S. News & World Report. The UAB Medicine Interventional Radiology (IR) team includes nationally and internationally recognized IR physicians, along with physician assistants, who strive to make excellence in patient care their highest priority. Each of the IR physicians at UAB Medicine is highly skilled, fellowship-trained, and board-certified by the American Board of Radiology.
Venita Gowdy: Uterine Fibroid Embolization
UAB is an active participant in research and clinical trials for uterine fibroids. We encourage you to speak to your physician about research and clinical trial options and browse the link below for more information.View Clinical Trials
Here are Some Tricks for a Heart-Healthy Halloween
Should You Be Afraid of a Halloween Heart Attack?
Sleep Center Chief Technologist Earns Unique Certification
UAB Cardiologist Provides Insider’s Perspective on the Field of Cardiovascular Medicine in New Book
UAB’s HCV+ Organ Transplant Program Extends to Heart and Lung Patients